Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ZIOP

Ziopharm

$3.89

0.03 (0.78%)

07:09
02/12/18
02/12
07:09
02/12/18
07:09
Hot Stocks
Ziopharm presents data on very rapid production of CAR T cells »

Ziopharm Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

Ziopharm

$3.46

-0.24 (-6.49%)

08:57
02/06/18
02/06
08:57
02/06/18
08:57
Hot Stocks
Ziopharm addresses rumors, stock volatility, backs guidance »

Ziopharm Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$22.45

-0.3 (-1.32%)

11:08
02/01/18
02/01
11:08
02/01/18
11:08
Hot Stocks
Novocure: Optune, temozolomide extended PFS, OS in patients in trial »

Novocure announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

ZIOP

Ziopharm

$4.28

-0.08 (-1.83%)

11:02
01/22/18
01/22
11:02
01/22/18
11:02
Periodicals
Ziopharm rise due to 'stupid money' inflow, Feuerstein says »

Adam Feuerstein tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ZIOP

Ziopharm

$4.20

-0.18 (-4.11%)

, BMY

Bristol-Myers

09:14
01/09/18
01/09
09:14
01/09/18
09:14
Hot Stocks
Ziopharm slides after pushing back start of pivotal cancer trial »

Shares of Ziopharm…

ZIOP

Ziopharm

$4.20

-0.18 (-4.11%)

BMY

Bristol-Myers

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 18

    Jan

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

NVCR

Novocure

$20.50

-0.3 (-1.44%)

07:38
01/09/18
01/09
07:38
01/09/18
07:38
Earnings
Novocure reports preliminary Q4 revenue $53.7M, consensus $53.35M »

Novocure reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

VBLT

VBL Therapeutics

$7.30

0.25 (3.55%)

07:03
12/27/17
12/27
07:03
12/27/17
07:03
Hot Stocks
VBL Therapeutics enrolls first patient in Phase 3 Study of VB-111 »

VBL Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$20.25

0.35 (1.76%)

11:08
12/19/17
12/19
11:08
12/19/17
11:08
Hot Stocks
Novocure says final analysis of Phase 3 Optune trial published in JAMA »

Novocure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBLT

VBL Therapeutics

$6.65

-0.05 (-0.75%)

17:08
12/18/17
12/18
17:08
12/18/17
17:08
Syndicate
Breaking Syndicate news story on VBL Therapeutics »

VBL Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VBLT

VBL Therapeutics

$6.70

-0.1 (-1.47%)

09:06
12/18/17
12/18
09:06
12/18/17
09:06
Hot Stocks
VBL says new biomarker data support VB-111's clinical effect »

VBL Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.